# US 6,730,794 B2 · Substituted indolealkanoic acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,794 B2
- Document ID: US6730794B2
- Status: Granted
- Kind: B2
- Application number: 10/185,863
- Filed: 2002-06-28
- Published: 2003-01-23
- Granted: 2004-05-04
- Earliest claimed: 1998-03-31
- Assignees: The Institute for Pharmaceutical Discovery, LLC
- Inventors: Michael Lee Jones; David Gunn; John Howard Jones; Michael C. Van Zandt
- Web page: https://patentgrep.com/patent/US6730794B2

## CPC

- C07D 417/06: linked by a carbon chain containing only aliphatic carbon atoms
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/08: for glucose homeostasis (pancreatic hormones A61P5/48)
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 13/12: of the kidneys
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/02: for peripheral neuropathies
- A61P 27/02: Ophthalmic agents
- A61P 27/12: for cataracts
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed are substituted indolealkanoic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.

## Claims

### Claim 1

A compound of the formula:
wherein
A is methylene;
Z is a bond;
R1 is hydrogen, alkyl having 1″6 carbon atoms, halogen, 2-, 3-, or 4-pyridyl, or phenyl, where the phenyl or pyridyl is optionally substituted with up to three groups selected from halogen, hydroxy, C1-C6 alkoxy, C1-C6 alkyl, nitro, amino, or mono- or di(C1-C6)alkylamino;
R2, R3, R4 and R5 are each independently
hydrogen, halogen, nitro, or an alkyl group of 1-6 carbon atoms (which may be substituted with one or more halogens);
OR7, SR7, S(O)R7, S(O)2N(R7)2, C(O)N(R7)2, or N(R7)2, wherein each R7 is independently hydrogen, an alkyl group of 1-6 carbon atoms (which may be substituted with one or more halogens) or benzyl, where the phenyl portion is optionally substituted with up to three groups independently selected from halogen, C1-C6 alkyl, C1-C6 alkoxy, amino, and mono- or di(C1-C6)alkylamino;
phenyl or heteroaryl such as 2-, 3- or 4-imidazolyl or 2-, 3-, or 4-pyridyl, each of which phenyl or heteroaryl is optionally substituted with up to three groups independently selected from halogen, C1-C6 alkyl, C1-C6 alkoxy, amino, and mono- or di(C1-C6)alkylamino;
phenoxy where the phenyl portion is optionally substituted with up to three groups independently selected from halogen, C1-C6 alkyl, C1-C6 alkoxy, amino, and mono- or di(C1-C6)alkylamino; or
a group of the formula
where
J is a bond, CH2, oxygen, or nitrogen; and each r is independently 2 or 3;
R6 is C1-C2 alkyl;
Ra is hydrogen or C1-C6 alkyl;
and Ar represents
a phenyl group optionally substituted with up to 5 groups independently selected from halogen, an alkyl group of 1-6 carbon atoms (which may be substituted with one or more halogens), nitro, OR7, SR7, S(O)R7, S(O)2R7, or N(R7)2 wherein R7 is hydrogen, an alkyl group of 1-6 carbon atoms (which may be substituted with one or more halogens) or benzyl, where the phenyl portion is optionally substituted with up to three groups independently selected from halogen, C1-C6 alkyl, C1-C6 alkoxy, amino, and mono- or di(C1-C6)alkylamino, or the phenyl group may be condensed with benzo where the benzo is optionally substituted with one or two of halogen, cyano, nitro, trifluoromethyl, perfluoroethyl, trifluoroacetyl, or (C1-C6)alkanoyl, hydroxy, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkylthio, trifluoromethoxy, trifluoromethylthio, (C1-C6)alkylsulfinyl, (C1-C6)alkylsulfonyl;
a heterocyclic 5-membered ring having one nitrogen, oxygen or sulfur, two nitrogens one of which may be replaced by oxygen or sulfur, or three nitrogens one of which may be replaced by oxygen or sulfur, said heterocyclic 5-membered ring substituted by one or two fluoro, chloro, (C1-C6)alkyl or phenyl, or condensed with benzo, or substituted by one of pyridyl, furyl or thienyl, said phenyl or benzo optionally substituted by one of iodo, cyano, nitro, perfluoroethyl, trifluoroacetyl, or (C1-C6)alkanoyl, one or two of fluoro, chloro, bromo, hydroxy, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkylthio, trifluoromethoxy, trifluoromethylthio, (C1-C6)alkylsulfinyl, (C1-C6)alkylsulfonyl or trifluoromethyl, or two fluoro or two trifluoromethyl with one hydroxy or one (C1-C6)alkoxy, or one or, preferably, two fluoro and one trifluoromethyl, or three fluoro, said pyridyl, furyl or thienyl optionally substituted in the 3-position by fluoro, chloro, bromo, (C1-C6)alkyl or (C1-C6)alkoxy;
a heterocyclic 6-membered ring having one to three nitrogen atoms, or one or two nitrogen atoms and one oxygen or sulfur, said heterocyclic 6-membered ring substituted by one or two (C1-C6)alkyl or phenyl, or condensed with benzo, or substituted by one of pyridyl, furyl or thienyl, said phenyl or benzo optionally substituted by one of iodo or trifluoromethylthio, or one or two of fluoro, chloro, bromo, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkylthio, (C1-C6)alkylsulfinyl, (C1-C6)alkylsulfonyl, or trifluoromethyl, and said pyridyl, furyl or thienyl optionally substituted in the 3-position by fluoro, chloro, (C1-C6)alkyl or (C1-C6)alkoxy;
said benzo-condensed heterocyclic 5-membered or 6-membered rings optionally substituted in the heterocyclic 5-membered or 6-membered ring by one of fluoro, chloro, bromo, methoxy, or trifluoromethyl;
oxazole or thiazole condensed with a 6-membered aromatic group containing one or two nitrogen atoms, with thiophene or with furane, each optionally substituted by one of fluoro, chloro, bromo, trifluoromethyl, methylthio or methylsulfinyl;
imidazolopyridine or triazolopyridine optionally substituted by one of trifluoromethyl, trifluoromethylthio, bromo, or (C1-C6)alkoxy, or two of fluoro or chloro;
thienothiophene or thienofuran optionally substituted by one of fluoro, chloro or trifluoromethyl;
thienotriazole optionally substituted by one of chloro or trifluoromethyl;
naphthothiazole; naphthoxazole; or thienoisothiazole.

### Claim 2 (depends on 1)

A compound according to claim 1, wherein Ar is aryl or heteroaryl, each of which is substituted with up to four groups independently selected from hydrogen, fluorine, chlorine, bromine, trifluoromethyl and nitro.

### Claim 3 (depends on 1)

A compound according to claim 1, wherein Ar is a substituted phenyl of Formula II or a substituted benzothiazole of Formula III
wherein R8, R8′, R9, R9′, R10, R11, R12, R13 and R14 are independently hydrogen, fluorine, chlorine, bromine, trifluoromethyl or nitro.

### Claim 4 (depends on 3)

A compound according to claim 3, wherein Ra is hydrogen.

### Claim 5 (depends on 4)

A compound according to claim 4, wherein Ar is a substituted benzothiazole of Formula III.

### Claim 6 (depends on 5)

A compound according to claim 5, wherein at least one of R11, R12, R13, and R14 is trifluoromethyl.

### Claim 7 (depends on 6)

A compound according to claim 6, wherein R12 is trifluoromethyl.

### Claim 8 (depends on 5)

A compound according to claim 5, wherein R11, R12, and R14 are fluorines and R13 is hydrogen.

### Claim 9 (depends on 4)

A compound according to claim 4, wherein Ar is a substituted phenyl of Formula II.

### Claim 10 (depends on 9)

A compound according to claim 9, wherein at least one of R8, R8′, R9, R9′, R10 is trifluoromethyl.

### Claim 11 (depends on 10)

A compound according to claim 10, wherein R9 is trifluoromethyl.

### Claim 12 (depends on 11)

A compound according to claim 11, wherein R8, R8′, R9, R9′, R10 are fluorines and R13 is hydrogen.

### Claim 13 (depends on 1)

A pharmaceutical composition comprising an effective amount of a compound according to any one of claims 1.

### Claim 14 (depends on 1)

A method of preventing or alleviating chronic complications arising from diabetes mellitus, which comprises administering to a mammal in need of such treatment an effective amount of a compound according to claim 1.

### Claim 15 (depends on 14)

A method according to claim 14 wherein the complications are selected from the group consisting of diabetic cataracts, retinopathy, nephropathy and neuropathy.

### Claim 16 (depends on 3)

A compound according to claim 3, wherein Ar is a substituted benzothiazole of Formula III, R12 is trifluoromethyl, A is methylene, methylene substituted with a methyl group, or ethylene, and R2, R3, R4 and R5, in combination, represent one of bromo, cyano or nitro, one or two of fluoro, chloro, hydroxy, (C1-C6)alkyl, (C1-C6)alkoxy, or trifluoromethyl, or two fluoro or two methyl with one hydroxy or one (C1-C6)alkoxy, or one or, preferably, two fluoro and one methyl, or three fluoro groups.

### Claim 17 (depends on 1)

A compound according to claim 1, which is 2-methyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 18 (depends on 1)

A compound according to claim 1, which is 5-chloro-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic Acid, ethyl ester.

### Claim 19 (depends on 1)

A compound according to claim 1, which is 5-methyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 20 (depends on 1)

A compound according to claim 1, which is 7-methyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 21 (depends on 1)

A compound according to claim 1, which is 6-chloro-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 22 (depends on 1)

A compound according to claim 1, which is 5-benzyloxy-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 23 (depends on 1)

A compound according to claim 1, which is 6-fluoro-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 24 (depends on 1)

A compound according to claim 1, which is 5-fluoro-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 25 (depends on 1)

A compound according to claim 1, which is 6-methyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 26 (depends on 1)

A compound according to claim 1, which is 3-(5-trifluoromethylbenzothiazol-2-yl)methyl-indole-N-acetic Acid, ethyl ester.

### Claim 27 (depends on 1)

A compound according to claim 1, which is 5-Methyl-3-(5-trifluoromethylbenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 28 (depends on 1)

A compound according to claim 1, which is 2-phenyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 29 (depends on 1)

A compound according to claim 1, which is 6-phenyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 30 (depends on 1)

A compound according to claim 1, which is 5-morpholino-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 31 (depends on 1)

A compound according to claim 1, which is 6-morpholino-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 32 (depends on 1)

A compound according to claim 1, which is 5-phenoxy-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid.

### Claim 33 (depends on 1)

A compound according to claim 1, which is 7-fluoro-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 34 (depends on 1)

A compound according to claim 1, which is 7-bromo-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 35 (depends on 1)

A compound according to claim 1, which is 7-chloro-3-(4,5,7-trifluorbenzothiazole-2-yl)methyl-indole-N-acetic acid, ethyl ester.

### Claim 36 (depends on 1)

A compound according to claim 1, which is 3-[5-Fluorbenzothiazole-2-yl]methyl-indole-N-acetic Acid, ethyl ester.

### Claim 37 (depends on 1)

A compound according to claim 1, which is 3-[6-Fluorbenzothiazole-2-yl]methyl-indole-N-acetic Acid, ethyl ester.

### Claim 38 (depends on 1)

A compound according to claim 1, which is 3-cyanomethyl-5-phenyl-indole-N-acetic acid, ethyl ester.
